Prevnar and Pneumovax
Links shared publicly online about this topic.
- 835total visits
Prevnar and Pneumovax
View full resource at afkpeds.org
Tags: Pneumococcal Vaccine, Vaccine, Prevnar
Most Recently Shared on September 30, 2010 at 11:55 pm By:
Just added http://bit.ly/bbtZSv to the Prevnar And Pneumovax WisdomCard http://bit.ly/a45CIj @organizedwisdom
Pneumococcus... | Facebook
facebook.com — “Journal of Allergy and Clinical Immunology wrote: Pneumococcus infections are a... Join Facebook to connect with Journal of Allergy and Clinical Immunology and others you may know.” View full resource at facebook.com
Most Recently Shared on March 25, 2012 at 6:40 pm By:
Juan C. Ivancevich, MD Doctor, Internist, Allergist, and Physician
Serotype-specific immune response to 12 month old infants following immunization with Pneumovax®. http://t.co/yGSWlXq4
Pfizer’s Prevnar 13 Phase 3 study for pneumococcal disease meets all study endpoints
news-medical.net — “Pfizer Inc. announced today that data from a Phase 3 study of Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) met all study endpoints, showing immunogenicity and establishing a safety profile in children and adolescents aged 5 through 17 years.” View full resource at news-medical.net
Most Recently Shared on March 12, 2012 at 4:16 pm By:
Meningitis News: Pfizer’s Prevnar 13 Phase 3 study for pneumococcal disease meets all study endpoints: Pfizer In... http://t.co/PztJUU3n
Phase 3 Study Update of Prevnar 13 for Pneumococcal Vaccination in Older Children and Adolescents - MPR
empr.com — “Pfizer announced that data from a Phase 3 study of Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) met all study endpoints, showing immunogenicity and establishing a safety profile in children and adolescents aged 5-17 years.” View full resource at empr.com
Most Recently Shared on March 12, 2012 at 2:26 pm By:
Phase 3 Study Update of #Prevnar 13 for Pneumococcal #Vaccination in Older Children and Adolescents http://t.co/lK3eB0L1 #immunization
UPDATE 1-Pfizer recalls expired lot of Prevnar vaccine | Reuters
reuters.com — “Feb 28 (Reuters) - Pfizer, the world's biggestdrugmaker, is recalling one batch of its Prevnar pneumoniavaccine because it was filled with expired material, U.S. drugregulators said.Pfizer began the” View full resource at reuters.com
Most Recently Shared on February 29, 2012 at 12:28 pm By:
Pfizer pulls one Prevnar lot b/c filled with expired material. FDA says caught early, at wholesale level http://t.co/650CWl8f $PFE
UPDATE 1-Pfizer says its drug is best hope for Alzheimer's - Yahoo! Finance UK
uk.finance.yahoo.com — “Read 'UPDATE 1-Pfizer says its drug is best hope for Alzheimer's' on Yahoo! Finance UK. * Says prior trials suggest edge over Lilly Alzheimer's drug * Says Prevnar 13 pneumonia data expected by 2013 * Expects FDA panel to review arthritis drug (Adds quotes from research chief, details on ...” View full resource at uk.finance.yahoo.com
Most Recently Shared on February 14, 2012 at 7:37 pm By:
UPDATE 1-Pfizer says its drug is best hope for Alzheimer's: * Says prior trials suggest edge over Lilly Alzheime... http://t.co/I53zjiUn
News in Brief: Week of Jan. 2-6 -- AAFP News Now -- American Academy of Family Physicians
aafp.org — “This roundup includes the following news briefs: Similarity in Drug Names Poses Serious Injury Risk, Says FDA; FDA Votes to Expand Prevnar 13 Indication; PCMHs, Physician-led Networks Generate Savings for N.C. Medicaid Program; HHS Awards Bonuses for State Medicaid, CHIP Program Expansions; and CHFM Seeks Fellowship Applicants.” View full resource at aafp.org
Most Recently Shared on January 6, 2012 at 1:36 am By:
News in Brief: Week of Jan. 2-6 http://t.co/9a7vkaXB
Pneumonia Vaccine Approved by FDA Called Prevnar 13 from Pfizer | Z6Mag
z6mag.com — “Pneumonia Vaccine Approved by FDA Called Prevnar 13 from Pfizer | Z6Mag” View full resource at z6mag.com
Most Recently Shared on January 4, 2012 at 10:04 pm By:
Healthcare In Focus Health Site
FDA approves new pneumonia vaccine, developed by Pfizer, for adults 50 and over http://t.co/mcMBlbBN @pfizer_news
FDA Greenlights Pneumonia Vaccine
medicalnewstoday.com — “The FDA has approved Prevnar 13, for use on people over 50. Prevnar 13 is a pneumococcal 13-valent conjugate vaccine, that can prevent pneumonia and disease caused by the bacterium, Streptococ” View full resource at medicalnewstoday.com
Most Recently Shared on January 2, 2012 at 6:05 pm By:
MedicalNewsToday: FDA Greenlights Pneumonia Vaccine http://t.co/CVwo11L4 Full http://t.co/XexlS93r
FDA approves Pfizer's Prevnar 13 pneumococcal conjugate vaccine as a single dose for adults
news-medical.net — “Pfizer Inc. announced today that the U.S. Food and Drug Administration has granted approval of the Company's pneumococcal conjugate vaccine Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) as a single dose for use in adults.” View full resource at news-medical.net
Most Recently Shared on December 31, 2011 at 9:55 am By:
Meningitis News: FDA approves Pfizer's Prevnar 13 pneumococcal conjugate vaccine as a single dose for adults: Pf... http://t.co/4eorFS2i
Senior Health Issues: Did You Know - Hebrew SeniorLife, for All Seniors of All Backgrounds
hebrewseniorlife.org — “Gerontology experts provide information about some of the most common senior health issues” View full resource at hebrewseniorlife.org
Most Recently Shared on December 19, 2011 at 9:00 pm By:
Hebrew SeniorLife Health Organization
Prevent Serious Illness with the Pneumovax Vaccine http://t.co/kMkuGDr5
The Germ-Fighting Warrior Priming Pfizer's Next Big Hit - Forbes
forbes.com — “Pfizer germ warrior Emilio Emini; photograph by Nathaniel Welch / Redux for Forbes This story appears in the Dec. 19, 2011, issue of Forbes Magazine. Emilio Emini’s battle with germs started early, when he was a working-class kid growing up on Sullivan Street in Manhattan’s Greenwich Village and was one of the [...]” View full resource at forbes.com
Most Recently Shared on November 30, 2011 at 11:37 pm By:
The next step at Pfizer: turbocharging the world's best-selling vaccine. http://t.co/SafUw3OB $PFE <--From the current Forbes Mag
Prevnar 13, the New 13-Valent Pneumococcal Conjugate Vaccine (December)
theannals.com — “Prevnar 13, the New 13-Valent Pneumococcal Conjugate Vaccine (December)” View full resource at theannals.com
Most Recently Shared on November 2, 2011 at 3:45 am By:
Prevnar 13, the New 13-Valent Pneumococcal Conjugate Vaccine (December): OBJECTIVE:To review the immunogenicity,... http://t.co/UCOTnIgs
Pfizer's Prevnar 13: Additional data from adult clinical studies presented at 49th IDSA
news-medical.net — “Pfizer Inc. announced today that additional data from several clinical studies of Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine) conducted in adults 50 years and older will be presented during the 49th Annual Meeting of the Infectious Diseases Society of America, which is being held Oct. 20-23, 2011, in Boston, Mass.” View full resource at news-medical.net
Most Recently Shared on October 22, 2011 at 5:24 pm By:
Meningitis News: Pfizer's Prevnar 13: Additional data from adult clinical studies presented at 49th IDSA: Pfizer... http://t.co/bq603Ytp
Additional Data From Pfizer's Prevnar 13 Clinical Trials In Adults 50 Years And Older To Be Presented At The 49th Annual Meeting Of The Infectious Diseases Society Of America - Drugs.com MedNews
drugs.com — “Oct 21, 2011 - Pfizer Inc. (NYSE PFE) announced today that additional data from several clinical studies of Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine” View full resource at drugs.com
Most Recently Shared on October 21, 2011 at 3:15 pm By:
Drugs and Devices OW OW Health
Additional Data From Pfizer's Prevnar 13 Clinical Trials In Adults 50 Years And Older To Be Presented At T... http://t.co/IqxTuLlB #drug
Arch Intern Med -- Abstract: Electronic Medical Record Reminders and Panel Management to Improve Primary Care of Elderly Patients, September 26, 2011, Loo et al. 171 (17): 1552
archinte.ama-assn.org — “Archives of Internal Medicine, a bi-monthly professional medical journal published by the American Medical Association, publishes original peer-reviewed research articles on internal medicine topics” View full resource at archinte.ama-assn.org
Most Recently Shared on October 4, 2011 at 9:21 pm By:
ArchInternalMedicine Medical Journal
#emr + #panelmanagement = better #pneumovax, #fluvax, healthcare power of attorney rates http://t.co/x8KhqfDf #hcr #pcmh #archinternmed
Advertisement
